This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1991 May 9;324(19):1362-5.

doi: 10.1056/NEJM199105093241911.

Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies

A L Hillman, J M Eisenberg, M V Pauly, B S Bloom, H Glick, B Kinosian, J S Schwartz

PMID: 1901959
DOI: 10.1056/NEJM199105093241911

Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies

A L Hillman et al. N Engl J Med. 1991.

. 1991 May 9;324(19):1362-5.

doi: 10.1056/NEJM199105093241911.

Authors

A L Hillman, J M Eisenberg, M V Pauly, B S Bloom, H Glick, B Kinosian, J S Schwartz

PMID: 1901959
DOI: 10.1056/NEJM199105093241911

No abstract available

PubMed Disclaimer

Comment in

Potential for bias in economic analyses.
[No authors listed] [No authors listed] N Engl J Med. 1991 Nov 7;325(19):1384-5. N Engl J Med. 1991. PMID: 1922247 No abstract available.

Similar articles

Academe, government, and the pharmaceutical industry: a tripod of necessity.
Bearn AG. Bearn AG. Prog Clin Biol Res. 1983;128:27-34. Prog Clin Biol Res. 1983. PMID: 6415661 Clinical Trial. No abstract available.
Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
Dorfman HL, Reig LP. Dorfman HL, et al. Food Drug Law J. 2004;59(4):595-615. Food Drug Law J. 2004. PMID: 15880876 No abstract available.
The role of pharmaceutical companies in sponsored research.
Novack GD. Novack GD. Ophthalmology. 2007 Jun;114(6):1037-8. doi: 10.1016/j.ophtha.2007.02.027. Ophthalmology. 2007. PMID: 17544773 No abstract available.
Medical-legal analysis and considerations in product liability cases involving pharmaceutical companies.
Woodside FC 3rd, Grunes AP, Comodeca JA. Woodside FC 3rd, et al. Leg Med. 1989:125-43. Leg Med. 1989. PMID: 2700004 Review. No abstract available.
Keynote review: Is declining innovation in the pharmaceutical industry a myth?
Schmid EF, Smith DA. Schmid EF, et al. Drug Discov Today. 2005 Aug 1;10(15):1031-9. doi: 10.1016/S1359-6446(05)03524-5. Drug Discov Today. 2005. PMID: 16055019 Review.

See all similar articles

Cited by

Quetiapine: a pharmacoeconomic review of its use in bipolar disorder.
Plosker GL. Plosker GL. Pharmacoeconomics. 2012 Jul 1;30(7):611-31. doi: 10.2165/11208500-000000000-00000. Pharmacoeconomics. 2012. PMID: 22559293 Review.
A critical evaluation of the volume, relevance and quality of evidence submitted by the tobacco industry to oppose standardised packaging of tobacco products.
Hatchard JL, Fooks GJ, Evans-Reeves KA, Ulucanlar S, Gilmore AB. Hatchard JL, et al. BMJ Open. 2014 Feb 12;4(2):e003757. doi: 10.1136/bmjopen-2013-003757. BMJ Open. 2014. PMID: 24523419 Free PMC article.
When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.
Catalá-López F, Sanfélix-Gimeno G, Ridao M, Peiró S. Catalá-López F, et al. PLoS One. 2013 Jul 8;8(7):e69462. doi: 10.1371/journal.pone.0069462. Print 2013. PLoS One. 2013. PMID: 23861972 Free PMC article.
Cost analysis of imipenem-cilastatin versus clindamycin with tobramycin in the treatment of acute intra-abdominal infection.
de Lissovoy G, Elixhauser A, Luce BR, Weschler J, Mowery P, Reblando J, Solomkin J. de Lissovoy G, et al. Pharmacoeconomics. 1993 Sep;4(3):203-14. doi: 10.2165/00019053-199304030-00005. Pharmacoeconomics. 1993. PMID: 10146923
A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?
Drummond MF. Drummond MF. Pharmacoeconomics. 1998 Jul;14(1):1-9. doi: 10.2165/00019053-199814010-00001. Pharmacoeconomics. 1998. PMID: 10182189

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.